Scribe Therapeutics (SCTX) makes new charter and bylaws effective with IPO closing
Rhea-AI Filing Summary
Scribe Therapeutics Inc. reported that its Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws became effective on July 27, 2026 in connection with the closing of its initial public offering of common stock.
The board of directors and stockholders had previously approved these governance documents to become effective immediately prior to the offering’s closing. Key terms of the charter and bylaws are described in the “Description of Capital Stock” section of the final prospectus dated July 23, 2026, and the full documents are filed as Exhibits 3.1 and 3.2.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.03, 9.01
2 items
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Effective date of charter/bylaws: July 27, 2026
Prospectus date: July 23, 2026
S-1 file number: 333-297246
3 metrics
Effective date of charter/bylaws
July 27, 2026
Date the amended and restated charter and bylaws became effective
Prospectus date
July 23, 2026
Date of final prospectus describing capital stock
S-1 file number
333-297246
File number of Registration Statement on Form S-1
Key Terms
Amended and Restated Certificate of Incorporation, Amended and Restated Bylaws, initial public offering, Registration Statement on Form S-1
4 terms
Amended and Restated Certificate of Incorporation regulatory
"filed its Amended and Restated Certificate of Incorporation (the “Charter”)"
A company’s amended and restated certificate of incorporation is an updated version of its foundational legal charter that replaces the older document and folds in all changes into one clear copy; it spells out corporate structure, classes of stock, shareholder rights and key governance rules. Investors care because it can change who controls the company, how votes are counted, what claims shareholders have on assets or dividends, and can introduce or remove protections against takeovers—like updating a house title after a major renovation to show who owns what and under what rules.
Amended and Restated Bylaws regulatory
"its Amended and Restated Bylaws (the “Bylaws”) became effective"
A company’s amended and restated bylaws are its internal rulebook rewritten to include all changes in one updated document, replacing the old bylaws. For investors, this matters because the bylaws set how the board, shareholders and officers make decisions, hold votes and handle disputes; a new consolidated version can change voting rights, control mechanisms or procedures that affect corporate governance and the value or risk of an investment.
initial public offering financial
"became effective in connection with the closing of the initial public offering"
An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.
Registration Statement on Form S-1 regulatory
"relating to the Registration Statement on Form S-1 (File No. 333-297246, as amended)"
A registration statement on Form S-1 is a detailed filing a company submits to the U.S. securities regulator to register new shares for public sale; it includes a plain-language prospectus, financial statements, business description and risk factors. For investors it matters because it provides the official, comprehensive blueprint of the offering — like an owner’s manual — allowing buyers to assess risks, inspect financial health and compare valuation before deciding to invest.
FAQ
What did Scribe Therapeutics Inc. (SCTX) change in its corporate documents?
Scribe Therapeutics Inc. made its Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws effective in connection with its IPO closing. These documents update the company’s governance framework as described in its final prospectus.
When did the new Scribe Therapeutics (SCTX) charter and bylaws become effective?
The amended and restated charter and bylaws became effective on July 27, 2026, immediately prior to the closing of Scribe Therapeutics’ initial public offering of common stock, following prior approval by its board and stockholders.
Where can investors find details of Scribe Therapeutics’ (SCTX) charter and bylaws?
Key provisions are summarized in the “Description of Capital Stock” section of the final prospectus dated July 23, 2026. The full charter and bylaws are filed as Exhibits 3.1 and 3.2 to this report.
What SEC registration statement covered Scribe Therapeutics’ (SCTX) IPO?
The IPO was conducted under a Registration Statement on Form S-1, File No. 333-297246, with a final prospectus dated July 23, 2026 filed pursuant to Rule 424(b) under the Securities Act of 1933.
AI-generated analysis. How Rhea-AI works. Not financial advice.
